Effects of yoga training in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
Original Article

Effects of yoga training in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

Xun-Chao Liu1,2*, Lei Pan3*, Qing Hu2, Wei-Ping Dong2, Jun-Hong Yan4, Liang Dong1

1Department of Respiratory Medicine, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China; 2Department of Respiratory Medicine, Heze Municipal Hospital, Heze, Shandong 274031, China; 3Department of Respiratory and Critical Care Medicine, 4Department of Clinical Medical Technology, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong 256603, China

*These authors contributed equally to this work.

Correspondence to: Liang Dong, MD. Department of Respiratory Medicine, Qilu Hospital of Shandong University, 107# Wenhua Xi Road, Jinan 250012, China. Email: qldongliang@163.com.

Introduction: Currently, several studies have assessed the effect of yoga training on the management of chronic obstructive pulmonary disease (COPD), but these studies involved a wide variation of sample and convey inconclusive results. Hence, the present study was performed a systematic review and meta-analysis to investigate the efficacy of yoga training in COPD patients.

Methods: PubMed, EMBASE, the Cochrane Library, Google Scholar, and ClinicalTrials.gov databases were searched for relevant studies. The primary outcomes were forced expiratory volume in one second (FEV1), FEV1% predicted (% pred). Secondary outcomes included 6-min walking distance (6 MWD), arterial oxygen tension (PaO2), and arterial carbon dioxide tension (PaCO2). Weighted mean differences (WMDs) and 95% confidence intervals (CIs) were calculated, and heterogeneity was assessed with the I2 test.

Results: Five randomized controlled trials (RCTs) involving 233 patients fulfilled the inclusion criteria. Yoga training significantly improved FEV1 (WMD: 123.57 mL, 95% CI: 4.12-243, P=0.04), FEV1% pred (WMD: 3.90%, 95% CI: 2.27-5.54, P<0.00001), and 6 MWD (WMD: 38.84 m, 95% CI: 15.52-62.16, P=0.001). However, yoga training had no significant effects on PaO2 (WMD: 1.29 mmHg, 95% CI: –1.21-3.78, P=0.31) and PaCO2 (WMD: –0.76 mmHg, 95% CI: –2.06-0.53, P=0.25).

Conclusions: The current limited evidence suggested that yoga training has a positive effect on improving lung function and exercise capacity and could be used as an adjunct pulmonary rehabilitation program in COPD patients. However, further studies are needed to substantiate our preliminary findings and to investigate the long-term effects of yoga training.

Keywords: Chronic obstructive pulmonary disease (COPD); yoga; pulmonary function; meta-analysis


Submitted Feb 18, 2014. Accepted for publication May 13, 2014.

doi: 10.3978/j.issn.2072-1439.2014.06.05


Introduction

Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality and poses a major public health problem. By 2020, COPD is predicted to rank as the third leading cause of death worldwide, whereas its social burden will rank fifth (1-3). COPD is characterized by irreversible airflow obstruction, a gradual decline in lung function, loss of lung tissue, reduced quality of life, and high rates of mortality. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) management includes a reduction in symptoms, complications, and exacerbations, improved exercise tolerance, improved health status, and reduced mortality (2). Recent evidence-based clinical practice guidelines and statements have shown that pulmonary rehabilitation is widely accepted as the most effective non-pharmacotherapy in the management of COPD (4). Research have indicated that various exercises, such as upper extremity exercise (5), Tai Chi (6), and yoga training (7), can relieve dyspnea, improve lung function, and improve the quality of life of COPD patients. Furthermore, a physical therapist-assisted intensive flexibility training that focuses on stretching and rib cage mobilization can significantly improve 6-min walking distance (6 MWD) (8).

Yoga originated in ancient India, and may denote the union between the individual self and the transcendental self. The body’s organs and systems are cleansed through asanas (postures) and pranayama (controlling the breath). Along with meditation, yoga asanas and pranayama have become popular in the West, and the practice of yoga has become “westernized.” Postures are taught as ends in themselves, that is, to heal an illness, reduce stress, or to look better (9). Yogic exercises have been shown to have positive effects on people with asthma (10,11), cardiac diseases (12), diabetes (13), tuberculosis (14), depressive disorders (15), osteoarthritis (16), and pleural effusion (17).

A number of clinical trials have suggested that yoga training may improve the pulmonary function of patients with COPD (18,19), but the quality of these studies have not been evaluated systematically. Therefore, we undertook a systematic review and meta-analysis of available randomized controlled trials (RCTs) to assess the efficacy of yoga training on pulmonary function and other clinical endpoints in patients with COPD.


Methods

Data sources and search strategy

The following electronic databases were searched: PubMed, Embase databases, Cochrane Central Register of Controlled Trials, Google Scholar, and ClinicalTrials.gov (until Jan 2014). The employed keywords were “yoga” and “COPD,” or “yoga” and “COPD”. The searches were limited to English publications in humans as well as RCTs. Bibliographies of all potentially relevant studies, articles (including unpublished data and meta-analyses), and international guidelines were manually searched. Furthermore, we also attempted to contact the authors of potentially relevant studies to obtain additional information.

Study selection

The following inclusive selection criteria inPICOS order involved the following: (I) population: patients with COPD; (II) intervention: yoga training with or without other treatments; (III) comparison intervention: any type of control; (IV) outcome measures: the primary outcomes were forced expiratory volume in one second (FEV1) and FEV1% predicted (% pred), whereas secondary outcomes included 6 MWD, arterial oxygen tension (PaO2), and arterial carbon dioxide tension (PaCO2); and (V) study design: RCT reported in a full paper article.

Data extraction

For each candidate article, Xun-Chao Liu and Lei Pan recorded the characteristics of the patients being studied, i.e., first author, year of publication, COPD stage, sample size of the study population (intervention/control), grade, staging, age, study design, Jadad scale, interventions (i.e., style of intervention, training frequency, exercise time, and duration), outcome parameters, and their results. Liang Dong checked all of the data. Disagreements were resolved by discussion.

Quality assessment and risk-of-bias assessment

The methodological quality of each research was evaluated using the Jadad scale (20). A score ≤2 indicates low quality, whereas a score ≥3 indicates high quality (21). The risk of bias was assessed using the Cochrane Handbook for Systematic Reviews of Interventions (http://ims.cochrane.org/revman). Two authors (Xun-Chao Liu and Lei Pan) subjectively reviewed all studies and assigned a value of ‘high,’ ‘low,’ or ‘unclear’ to the following: (I) selection bias (was there adequate generation of the randomization sequence? was allocation concealment satisfactory?); (II) blinding (i.e., performance bias and detection bias) (was there blinding of participants, personnel, and outcome assessment?); (III) attrition bias (were incomplete outcome data sufficiently assessed and dealt with?); (IV) reporting bias (was there evidence of selective outcome reporting?); and (V) other biases (was the study apparently free of other problems that could place it at a high risk of bias?).

Statistical analysis

This systematic review and meta-analysis is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (22). We used Revman version 5.1 software for all data and statistical analyses. For continuous outcomes, the pooled mean difference was calculated by using the weighted mean difference (WMD). Heterogeneity was assessed with the I2 statistic and defined as low (I2≤25%), moderate (25%<I2≤50%), or high (I2>50%) (23,24). A random-effects model was undertaken whether heterogeneity was high or not. Potential publication bias was not assessed because of the limited number of studies (<10) included in each analysis. A P value of <0.05 was considered statistically significant. The overall treatment effect was compared with its minimal clinically important difference (MCID).


Results

Bibliographic search

Figure 1 shows the study search process according to PRISMA guidelines (22). Of the 11 studies retrieved from the initial search, six met our inclusion criteria (7,18,19,25-27), but one study was excluded upon secondary analysis (27). The reasons for exclusion are presented in Figure 1. Finally, five RCTs, which had a combined cohort size of 233 participants, were selected for this meta-analysis, and their main characteristics are presented in Table 1. The sample size per RCT ranged from 30 to 100. These studies were published between 1978 and 2012, and their duration ranged from 12 weeks to 9 months. Four RCTs reported FEV1 (18,19) or FEV1% (7,25), and two RCTs reported 6 MWD (7,25). Meanwhile, two RCTs reported PaO2 and PaCO2 (18,19). The mean Jadad score of the studies included was 2.4 (SD=0.89). The risk of bias analysis is presented in Table 2.

Figure 1 Search strategy and flow chart of screened, excluded, and eventually analyzed articles.
Table 1
Table 1 Characteristics of randomized controlled trials included in the meta-analysis
Full table
Table 2
Table 2 Assessing risk of bias
Full table

Primary outcomes

Two RCTs reported primary outcomes as FEV1 (18,19), and another two RCTs reported FEV1% pred (7,25). The aggregate results of these studies suggested that yoga training was associated with a significant improvement in FEV1 [WMD: 123.57 mL, 95% confidence interval (CI): 4.12-243, P=0.04] (Figure 2) and FEV1% (WMD: 3.90, 95% CI: 2.27-5.54, P<0.00001) (Figure 3). The test for heterogeneity was not significant (FEV1: P for heterogeneity=0.68, I2=0%; FEV1%: P for heterogeneity=0.39, I2=0%). We subsequently performed sensitivity analyses to explore potential sources of heterogeneity. The mean changes of FEV1 were greater than the MCID (>100 mL) (28).

Figure 2 Meta-analysis of randomized controlled trials evaluating effects of yoga training on FEV1 by the random-effects model. FEV1, forced expiratory volume in one second.
Figure 3 Meta-analysis of randomized controlled trials evaluating effects of yoga training on FEV1% by the random-effects model. FEV1, forced expiratory volume in one second.

Secondary outcomes

Meanwhile, two RCTs reported results in terms of 6 MWD (7,25). The aggregate results of these studies suggested that yoga training was associated with a statistically significant improvement in 6 MWD (WMD: 38.84 m, 95% CI: 15.52-62.16, P=0.001). The results for the heterogeneity test was not significant (P for heterogeneity=0.08, I2=67%) (Figure 4). Subsequently, the mean changes of 6 MWD were greater than the MCID (>26 m) (29). Two RCTs reported PaO2 and PaCO2 (18,19), and these studies suggested that yoga training was not associated with a significant difference on PaO2 (WMD: 1.29 mmHg, 95% CI: –1.21-3.78, P=0.31) or PaCO2 (WMD: –0.76 mmHg, 95% CI: –2.06-0.53, P=0.25). The test for heterogeneity was not significant (PaO2: P for heterogeneity=0.47, I2=0%; PaCO2: P for heterogeneity=0.23, I2=31%) (Figures 5,6).

Figure 4 Meta-analysis of randomized controlled trials evaluating effects of yoga training on 6WMD by the random-effects model. WMD, weighted mean difference.
Figure 5 Meta-analysis of randomized controlled trials evaluating effects of yoga training on PaO2 by the random-effects model. PaO2, arterial oxygen tension.
Figure 6 Meta-analysis of randomized controlled trials evaluating effects of yoga training on PaCO2 by the random-effects model. PaCO2, arterial carbon dioxide tension.

Discussion

This study is the first meta-analysis to evaluate the effects of yoga training on COPD patients. Our results suggested that yoga training has a positive improvement effect on lung function and exercise capacity and could be used as an adjunct pulmonary rehabilitation program for COPD patients.

Currently, no drugs could hinder the progress of COPD, but lung training and pulmonary rehabilitation have been shown to reduce disability in many chronic respiratory diseases and have become valuable means of COPD treatment (30-33). Studies have indicated an increase in tidal volume and FVC, reduction in respiratory rate, increase in FEV1, FEV1%, maximum voluntary ventilation, and breath holding capacity after short-term yoga practice (34,35). Furthermore, studies suggested that yoga training may improve exercise capacity, prevent lung function decline, improve quality of life, and reduce dyspnea in patients with COPD (36,37). However, these studies did not provide adequate data or sufficient clinical evidence to support the beneficial effects of yoga training on these relevant findings.

Our results suggested that yoga training improved FEV1 or FEV1% pred in four studies (7,18,19,25). However, the results required comparison with the MCID, which is defined as the smallest change in the measurement used to evaluate the clinical significance of intervention effects. The MCID is claimed to be a 100-mL change in FEV1 from baseline (28), and the 123.57 mL increment in FEV1 in our study is greater than the MCID. This result indicates that yoga training can have a clinical effect on COPD patients. Unfortunately, we failed to compare further the FEV1% pred with the MCID because of insufficient available data. Our meta-analysis also found that yoga training statistically improved 6 MWD in patients with COPD. The 38.84 m change for 6 MWD was greater than the MCID (≥26 m) (29). However, our meta-analysis showed that yoga training did not affect arterial blood gas analyses, which included PaO2 and PaCO2. PaO2 and PaCO2 are affected by various factors, such as temperature factors (38), breathing frequency (39), varying levels of light intensities (40), sampling location, blood volume, and inspection time (41). We believed that PaO2 and PaCO2 are not suitable evaluation parameters of yoga training in COPD patients because of their instability. However, further study is needed to investigate this noteworthy topic.

The mechanisms of yoga training responsible for its beneficial effects that differ from other forms of exercise have yet to be elucidated. Several factors may be responsible for the beneficial effects seen in the patients undergoing yoga training aside from exercises (42-45). Yoga training aids in toning up general body systems (42), increasing respiratory stamina, relaxing chest muscles, expanding the lungs, raising energy levels, and calming the body (43). Additionally, yoga training improves blood circulation and increases the strength of respiratory muscles (44). Finally, yoga training also helps patients to breathe more deeply by utilizing the shoulder, thoracic, and abdominal muscles efficiently (45).

Yoga training can provide a complementary strategy for patients with COPD. Apart from relaxing tense muscles, yoga can also alleviate mental pressure (15). However further studies are needed to examine the effectiveness of yoga training compared with other breathing exercises. Our study showed follow-up durations that ranged from 12 weeks to 9 months, and the long-term effects of yoga training optimal exercise duration currently remain unknown. Future research should focus on optimizing training intensity, duration, and frequency. Moreover, it should be emphasized that the severity may greatly influence the effect of yoga. However, not all studies have noted the severity of COPD patients. Further research should focus on the relationship between the severity and efficacy in COPD patients, which can help to determine the best yoga exercise prescription and the best suitable patients. Finally, most studies lacked other physiological outcome measures, such as inflammatory biomarkers, continuous monitoring, sensitive measures of change, and peripheral muscle strength. Further studies that focus on these will enrich clinical evidence regarding yoga.

Several limitations are identified in our study. First, included trials significantly varied in terms of interventions protocol, duration, patient populations, severity, and study quality, which limit the conclusive extent for the overall effectiveness of yoga training on FEV1, FEV1% pred, 6 MWD, and blood gas analysis in COPD patients. Secondly, our analysis is based on only five RCTs, and only a maximum of two studies were available for the main outcomes. In addition, studies ranged from 1978 to 2012 hence it encompasses a wide time frame which may affect the results as over the years better drugs are available such anticholinergics to ameliorate symptoms of COPD and more standardized and accurate methods are available to measure some clinical endpoints such as lung function and arterial blood gas analysis. Moreover, these studies have a wide variation in patient populations. The smaller sample size of trials may have significantly overestimated the treatment effect. Finally, several missing and unpublished data may lead to bias.


Conclusions

Our meta-analysis suggested that yoga training that lasts from 12 weeks to 9 months may improve lung function and functional exercise capacity in patients with COPD compared with conventional therapy. Moreover, we suggest that yoga could be a useful adjunct pulmonary rehabilitation program for COPD patients. To help clarify the issue, further rigorously designed, larger-scale trials should be conducted to evaluate the long-term effects of yoga training in COPD patients.


Acknowledgements

We would like to thank the authors of the original studies included in this meta-analysis.

Disclosure: The authors declare no conflict of interest.


References

  1. Viegi G, Pistelli F, Sherrill DL, et al. Definition, epidemiology and natural history of COPD. Eur Respir J 2007;30:993-1013. [PubMed]
  2. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65. [PubMed]
  3. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-76. [PubMed]
  4. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011;155:179-91. [PubMed]
  5. Pan L, Guo YZ, Yan JH, et al. Does upper extremity exercise improve dyspnea in patients with COPD? A meta-analysis. Respir Med 2012;106:1517-25. [PubMed]
  6. Yan JH, Guo YZ, Yao HM, et al. Effects of Tai Chi in patients with chronic obstructive pulmonary disease: preliminary evidence. PLoS One 2013;8:e61806. [PubMed]
  7. Donesky-Cuenco D, Nguyen HQ, Paul S, et al. Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study. J Altern Complement Med 2009;15:225-34. [PubMed]
  8. Yoshimi K, Ueki J, Seyama K, et al. Pulmonary rehabilitation program including respiratory conditioning for chronic obstructive pulmonary disease (COPD): Improved hyperinflation and expiratory flow during tidal breathing. J Thorac Dis 2012;4:259-64. [PubMed]
  9. Garfinkel M, Schumacher HR Jr. Yoga. Rheum Dis Clin North Am 2000;26:125-32. [PubMed]
  10. Manocha R, Marks GB, Kenchington P, et al. Sahaja yoga in the management of moderate to severe asthma: a randomised controlled trial. Thorax 2002;57:110-5. [PubMed]
  11. Sabina AB, Williams AL, Wall HK, et al. Yoga intervention for adults with mild-to-moderate asthma: a pilot study. Ann Allergy Asthma Immunol 2005;94:543-8. [PubMed]
  12. Jayasinghe SR. Yoga in cardiac health (a review). Eur J Cardiovasc Prev Rehabil 2004;11:369-75. [PubMed]
  13. Malhotra V, Singh S, Tandon OP, et al. The beneficial effect of yoga in diabetes. Nepal Med Coll J 2005;7:145-7. [PubMed]
  14. Visweswaraiah NK, Telles S. Randomized trial of yoga as a complementary therapy for pulmonary tuberculosis. Respirology 2004;9:96-101. [PubMed]
  15. Sharma VK, Das S, Mondal S, et al. Effect of Sahaj Yoga on depressive disorders. Indian J Physiol Pharmacol 2005;49:462-8. [PubMed]
  16. Ernst E. Complementary or alternative therapies for osteoarthritis. Nat Clin Pract Rheumatol 2006;2:74-80. [PubMed]
  17. Prakasamma M, Bhaduri A. A study of yoga as a nursing intervention in the care of patients with pleural effusion. J Adv Nurs 1984;9:127-33. [PubMed]
  18. Tandon MK. Adjunct treatment with yoga in chronic severe airways obstruction. Thorax 1978;33:514-7. [PubMed]
  19. Kulpati DD, Kamath RK, Chauhan MR. The influence of physical conditioning by yogasanas and breathing exercises in patients of chronic obstructive lung disease. J Assoc Physicians India 1982;30:865-8. [PubMed]
  20. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. [PubMed]
  21. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001;135:982-9. [PubMed]
  22. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700. [PubMed]
  23. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58. [PubMed]
  24. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. [PubMed]
  25. Katiyar SK, Bihari S. Role of pranayama in rehabilitation of COPD patients–a randomized controlled study. Indian J Allergy Asthma Immunol 2006;20:98-104.
  26. Soni R, Munish K, Singh K, et al. Study of the effect of yoga training on diffusion capacity in chronic obstructive pulmonary disease patients: A controlled trial. Int J Yoga 2012;5:123-7. [PubMed]
  27. Donesky D, Melendez M, Nguyen HQ, et al. A responder analysis of the effects of yoga for individuals with COPD: who benefits and how? Int J Yoga Therap 2012:23-36.
  28. Donohue JF. Minimal clinically important differences in COPD lung function. COPD 2005;2:111-24. [PubMed]
  29. Puhan MA, Chandra D, Mosenifar Z, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011;37:784-90. [PubMed]
  30. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348:1115-9. [PubMed]
  31. Singh V. Effect of respiratory exercises on asthma. The Pink City lung exerciser. J Asthma 1987;24:355-9. [PubMed]
  32. Singh V, Wisniewski A, Britton J, et al. Effect of yoga breathing exercises (pranayama) on airway reactivity in subjects with asthma. Lancet 1990;335:1381-3. [PubMed]
  33. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007;131:4S-42S. [PubMed]
  34. Makwana K, Khirwadkar N, Gupta HC. Effect of short term yoga practice on ventilatory function tests. Indian J Physiol Pharmacol 1988;32:202-8. [PubMed]
  35. Joshi LN, Joshi VD, Gokhale LV. Effect of short term ‘Pranayam’ practice on breathing rate and ventilatory functions of lung. Indian J Physiol Pharmacol 1992;36:105-8. [PubMed]
  36. Behera D. Yoga therapy in chronic bronchitis. J Assoc Physicians India 1998;46:207-8. [PubMed]
  37. Fulambarker A, Farooki B, Kheir F, et al. Effect of yoga in chronic obstructive pulmonary disease. Am J Ther 2012;19:96-100. [PubMed]
  38. Bradley AF, Severinghaus JW, Stupfel M. Effect of temperature on PCO2 and PO2 of blood in vitro. J Appl Physiol 1956;9:201-4. [PubMed]
  39. Kapus J, Ušaj A, Kapus V, et al. The influence of reduced breathing during swimming on some respiratory and metabolic values in blood. KinSI 2002;8:14-8.
  40. Olanrewaju HA, Purswell JL, Collier SD, et al. Effect of varying light intensity on blood physiological reactions of broiler chickens grown to heavy weights. Int J Poult Sci 2012;11:81-7.
  41. Cunningham DJ, Cormack RS, O’Riordan JL, et al. An arrangement for studying the respiratory effects in man of various factors. Q J Exp Physiol Cogn Med Sci 1957;42:294-303. [PubMed]
  42. Udupa KN, Singh RH. The scientific basis of yoga. JAMA 1972;220:1365. [PubMed]
  43. Chanavirut R, Khaidjapho K, Jaree P, et al. Yoga exercise increases chest wall expansion and lung volumes in young healthy thais. Thai J Physiol Sci 2006;19:1-7.
  44. Posadzki P, Parekh S. Yoga and physiotherapy: a speculative review and conceptual synthesis. Chin J Integr Med 2009;15:66-72. [PubMed]
  45. Vedanthan P. Yoga breathing techniques (YBT) in chronic obstructive pulmonary disease (COPD): a preliminary study. Int J Yoga Ther 2003;13:51-4.
Cite this article as: Liu XC, Pan L, Hu Q, Dong WP, Yan JH, Dong L. Effects of yoga training in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Thorac Dis 2014;6(6):795-802. doi: 10.3978/j.issn.2072-1439.2014.06.05